Our Commitment to Advancing Medical Research
2 in every 3 Australians will be diagnosed with skin cancer by the time they are 70.*
According to the Cancer Council, Australia has one of the highest rates of skin cancer in the world. Around 2,000 of us die from the disease every single year!**
Our people should not be suffering and dying at the hands of our beautiful Aussie weather! At Re-Dox, we think these stats are unacceptable, and we want to do something about it.
As scientists ourselves, we know research is the foundation of both preventing and curing disease, and because of this, we are pledging to donate $2 from every sale to skin cancer research.
*Cancer Council of Australia **Australian Bureau of Statistics
Why us, why skin cancer?
Our founder, Dr Belal Chami, is a devoted medical researcher who works closely with leading institutions, laboratories, and medical professionals to advance our understanding of human diseases. He is passionate about supporting medical research in Australia and equally passionate about the skin health of Australians.
Inspired by the urgency to find effective treatments and preventive measures, we at Re-Dox have committed ourselves to contribute to the advancement of skin cancer research.
We firmly believe that by combining the power of scientific innovation and compassionate consumerism, we can make a tangible difference in the lives of those affected by this devastating illness.
When you choose Re-Dox, you are not just investing in your own skincare routine, but you are also investing in cutting-edge research and solutions to combat skin cancer.
Your purchase directly supports organisations at the forefront of skin cancer research, enabling them to pursue groundbreaking studies, clinical trials, and initiatives aimed at improving detection, prevention, and treatment options
Through collaborations and knowledge-sharing, we aim to push the boundaries of scientific understanding and develop advanced skincare products that not only nourish and protect your skin but also contribute to the ongoing battle against this formidable disease.
